Literature DB >> 23668026

[Clinical study of decoction of invigorating Qi and clearing lung combined standardized myrtol on acute exacerbation of chronic obstructive pulmonary disease (AECOPD)].

Zhao-Quan Hua1, Yi-Jie Chang.   

Abstract

OBJECTIVE: To investigate the clinical effect of decoction of invigorating Qi and clearing lung combined standardized myrtol on acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
METHOD: Ninety and eight patients with AECOPD patients were randomly divided into the treatment group and the control group, with 50 cases and 48 cases respectively. All the patients were given the conventional treatment. The control group was treated by standardized myrtol with 3 times a day, 300 mg each time taken orally. The treatment group was given decoction of invigorating Qi and clearing lung with 2 times a day, one dose per day taken orally, combined standardized myrtol (usage as above). After Two weeks, the scores of clinical symptom, blood gas analysis and pulmonary function were observed. RESULT: Both FEV1 and FEV1% were raised in the two groups after treating. And the treatment group was significantly higher than control group (P < 0.01). PaO2 and PaO2/FiO2 rose, with PaCO2 decreased in the two groups (P < 0.01). PaO2 and PaO2/FiO2 were significantly improved, and PaCO2 was significantly decreased in the treatment group compared to the control group (P < 0.01). In the clinical curative effect comparison aspects, clinical control rates were 42.0% in treatment group and 20.83% in control group respectively, with significant difference between the two groups (P < 0.05). Significant efficiency is 86.0% in treatment group and 52.08% in control group respectively, with significant difference between the two groups (P < 0.01).
CONCLUSION: Decoction of invigorating Qi and clearing lung combined with standardized myrtol can obviously improve clinical symptom, blood gas an analysis and pulmonary function in patients with AECOPD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23668026

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

Review 1.  Safety of chinese herbal medicine for chronic obstructive pulmonary disease.

Authors:  Meaghan Coyle; Johannah Linda Shergis; Shaonan Liu; Lei Wu; Anthony Lin Zhang; Xinfeng Guo; Chuanjian Lu; Charlie Changli Xue
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-26       Impact factor: 2.629

Review 2.  Is Myrtol® Standardized a New Alternative toward Antibiotics?

Authors:  Maria Paparoupa; Adrian Gillissen
Journal:  Pharmacogn Rev       Date:  2016 Jul-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.